Shaun Bender

751 total citations
38 papers, 396 citations indexed

About

Shaun Bender is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Shaun Bender has authored 38 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Shaun Bender's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers) and Transplantation: Methods and Outcomes (5 papers). Shaun Bender is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers) and Transplantation: Methods and Outcomes (5 papers). Shaun Bender collaborates with scholars based in United States, Germany and United Kingdom. Shaun Bender's co-authors include Scott M. Palmer, Craig Conoscenti, Megan L. Neely, Thomas B. Leonard, João A. de Andrade, Laurie D. Snyder, Daniel A. Culver, Anne S. Hellkamp, Donald F. Zoz and Eric Yow and has published in prestigious journals such as Nature Medicine, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Shaun Bender

31 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaun Bender United States 13 276 141 44 39 37 38 396
H. James Ford United States 10 290 1.1× 124 0.9× 77 1.8× 15 0.4× 41 1.1× 28 398
Xintong He China 7 159 0.6× 107 0.8× 26 0.6× 37 0.9× 58 1.6× 17 283
Qun Luo China 9 110 0.4× 73 0.5× 13 0.3× 31 0.8× 70 1.9× 25 292
Ioannis Tomos Greece 7 250 0.9× 34 0.2× 31 0.7× 10 0.3× 25 0.7× 33 315
Hiroshi Kinashi Japan 10 79 0.3× 45 0.3× 68 1.5× 31 0.8× 16 0.4× 41 301
Taysir Mahmoud United States 5 130 0.5× 104 0.7× 13 0.3× 37 0.9× 57 1.5× 10 280
Yasuhiro Choda Japan 11 208 0.8× 121 0.9× 275 6.3× 11 0.3× 37 1.0× 53 486
B. Díaz-López Spain 8 48 0.2× 149 1.1× 115 2.6× 58 1.5× 17 0.5× 9 382
Anirban Ganguli India 9 145 0.5× 42 0.3× 27 0.6× 107 2.7× 8 0.2× 17 433
Leopoldo Fernandez‐Alonso Spain 9 119 0.4× 66 0.5× 145 3.3× 11 0.3× 31 0.8× 22 361

Countries citing papers authored by Shaun Bender

Since Specialization
Citations

This map shows the geographic impact of Shaun Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaun Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaun Bender more than expected).

Fields of papers citing papers by Shaun Bender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaun Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaun Bender. The network helps show where Shaun Bender may publish in the future.

Co-authorship network of co-authors of Shaun Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Shaun Bender. A scholar is included among the top collaborators of Shaun Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaun Bender. Shaun Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Jin, Thomas L. Nickolas, Shaun Bender, et al.. (2025). Corticosteroid, Parathyroid Hormone, and Body Composition Associations With Bone Density and Structure Following Kidney Transplantation. American Journal of Kidney Diseases. 87(3). 298–312.e1.
2.
Maurer, Matthew J., et al.. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. 85(7). 744–752. 1 indexed citations
3.
Jering, Karola, Marianna Fontana, Olivier Lairez, et al.. (2025). Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial. Nature Medicine. 31(10). 3560–3568. 2 indexed citations
4.
Maurer, Matthew J., John L. Berk, Thibaud Damy, et al.. (2025). Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B. Journal of the American College of Cardiology. 86(6). 459–475.
5.
Jering, Karola, Hicham Skali, Bernard E. Bulwer, et al.. (2025). Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy. Journal of the American College of Cardiology. 86(6). 444–455.
6.
Ji, Xinge, Pratik Pimple, Amy L. Olson, et al.. (2024). Proportion and predictors of FVC decline in patients with interstitial lung disease. Respiratory Medicine. 227. 107656–107656.
7.
Strand, Vibeke, Shaun Bender, & Dorothy McCabe. (2024). Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA. Rheumatology and Therapy. 11(5). 1291–1302.
8.
9.
Astor, Todd L., Hilary J. Goldberg, Laurie D. Snyder, et al.. (2023). Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease. 17. 2683745240–2683745240. 4 indexed citations
10.
Neely, Megan L., Anne S. Hellkamp, Shaun Bender, et al.. (2023). Lung function trajectories in patients with idiopathic pulmonary fibrosis. Respiratory Research. 24(1). 209–209. 9 indexed citations
11.
Andrade, João A. de, Megan L. Neely, Anne S. Hellkamp, et al.. (2023). Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis. Clinical Therapeutics. 45(4). 306–315. 16 indexed citations
12.
Swaminathan, Aparna, Anne S. Hellkamp, Megan L. Neely, et al.. (2022). Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry. Annals of the American Thoracic Society. 19(6). 981–990. 20 indexed citations
13.
Snyder, Laurie D., Megan L. Neely, Anne S. Hellkamp, et al.. (2022). Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry. Lung. 200(1). 21–29. 7 indexed citations
14.
Bender, Shaun, et al.. (2022). Use of Concurrent Anti-diabetes Medications in Patients With Type 2 Diabetes in Clinical Practice in the United States. Clinical Therapeutics. 44(9). 1248–1256. 4 indexed citations
15.
Case, Amy Hajari, Anne S. Hellkamp, Megan L. Neely, et al.. (2020). Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Annals of the American Thoracic Society. 17(6). 699–705. 18 indexed citations
16.
Lasky, Joseph A., et al.. (2020). Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data. Advances in Therapy. 37(10). 4209–4219. 26 indexed citations
17.
Astor, Todd L., Hilary J. Goldberg, Laurie D. Snyder, et al.. (2020). Impact of Pre-Transplant Anti-Fibrotic Therapy for IPF Upon Lung Transplant Outcomes. A2844–A2844. 2 indexed citations
18.
Salisbury, Margaret L., Craig Conoscenti, Daniel A. Culver, et al.. (2020). Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry. Annals of the American Thoracic Society. 17(11). 1413–1423. 33 indexed citations
19.
Bender, Shaun, Craig Conoscenti, Linda Davidson‐Ray, et al.. (2020). Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. CHEST Journal. 157(6). 1522–1530. 17 indexed citations
20.
Snyder, Laurie D., Megan L. Neely, Anne S. Hellkamp, et al.. (2019). Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Respiratory Research. 20(1). 105–105. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. James Ford Breakdown of academic impact, for papers by Xintong He Breakdown of academic impact, for papers by Qun Luo Breakdown of academic impact, for papers by Ioannis Tomos Breakdown of academic impact, for papers by Hiroshi Kinashi Breakdown of academic impact, for papers by Taysir Mahmoud Breakdown of academic impact, for papers by Yasuhiro Choda Breakdown of academic impact, for papers by B. Díaz-López Breakdown of academic impact, for papers by Anirban Ganguli Breakdown of academic impact, for papers by Leopoldo Fernandez‐Alonso
Rankless by CCL
2026